CryoPort (NASDAQ:CYRX) will be announcing its earnings results after the market closes on Thursday, November 8th. Analysts expect the company to announce earnings of ($0.08) per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.
CryoPort (NASDAQ:CYRX) last issued its quarterly earnings data on Thursday, August 9th. The consumer goods maker reported ($0.09) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.07) by ($0.02). The company had revenue of $4.63 million for the quarter, compared to the consensus estimate of $4.36 million. CryoPort had a negative net margin of 62.80% and a negative return on equity of 45.60%. CryoPort’s revenue was up 58.6% compared to the same quarter last year. On average, analysts expect CryoPort to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Shares of NASDAQ CYRX opened at $11.46 on Tuesday. The firm has a market cap of $330.29 million, a price-to-earnings ratio of -33.71 and a beta of 1.42. CryoPort has a 52-week low of $6.02 and a 52-week high of $16.88.
A number of research analysts have issued reports on CYRX shares. BidaskClub cut CryoPort from a “buy” rating to a “hold” rating in a report on Wednesday, August 15th. Cowen lifted their price target on CryoPort from $11.00 to $16.00 and gave the company an “outperform” rating in a report on Monday, August 13th. Finally, B. Riley began coverage on CryoPort in a report on Wednesday, October 10th. They issued a “buy” rating and a $22.00 price target for the company. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $19.75.
In related news, CEO Richard J. Berman sold 20,000 shares of CryoPort stock in a transaction dated Wednesday, August 15th. The stock was sold at an average price of $12.81, for a total value of $256,200.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Richard J. Berman sold 10,000 shares of CryoPort stock in a transaction dated Thursday, September 6th. The shares were sold at an average price of $14.00, for a total value of $140,000.00. The disclosure for this sale can be found here. Insiders own 9.60% of the company’s stock.
An institutional investor recently raised its position in CryoPort stock. Bank of New York Mellon Corp boosted its position in shares of CryoPort Inc (NASDAQ:CYRX) by 195.5% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 76,388 shares of the consumer goods maker’s stock after purchasing an additional 50,538 shares during the quarter. Bank of New York Mellon Corp owned about 0.27% of CryoPort worth $1,205,000 as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 48.25% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This report was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another publication, it was illegally stolen and republished in violation of US and international trademark & copyright law. The original version of this report can be accessed at https://www.dispatchtribunal.com/2018/11/06/cryoport-cyrx-scheduled-to-post-quarterly-earnings-on-thursday.html.
CryoPort Company Profile
Cryoport, Inc provides cryogenic logistics solutions to the life sciences industry in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, a dry vapor cryogenic shipper that use liquid nitrogen contained inside a vacuum insulated vessel, which serves as a refrigerant to provide stable storage temperatures.
Recommended Story: How Investors Use a Balance Sheet
Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.